U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07570940) titled 'A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery' on April 30.
Brief Summary: The purpose of this study is assess the incidence of postoperative atrial fibrillation (POAF) within one week of surgery in patients who receive pre-surgical stellate ganglion blockade with liposomal bupivacaine, compared to those receiving a saline placebo, using continuous electrocardiographic monitoring via wearable ECG devices.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Coronary Artery Disease
Atrial Fibrillation
Intervent...